CorMedix Inc. (CRMD) |
|
6.15 0.02 (0.33%)
|
12-06 16:00 |
|
Open: |
6.15 |
Pre. Close: |
6.13 |
|
High:
|
6.29 |
Low:
|
6.07 |
|
Volume:
|
173,942 |
Market Cap:
|
158M |
|
|
|
|
Cormedix Inc is a commercial-stage biopharmaceutical company. It focuses on development and commercializing prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
6.298 - 6.322 |
6.322 - 6.346 |
|
Low:
|
6.007 - 6.036 |
6.036 - 6.065 |
|
Close:
|
6.104 - 6.148 |
6.148 - 6.192 |
|
Technical analysis |
as of: 2019-12-06 4:33:40 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 8.29 One year: 9.69 |
| Support: |
Support1: 5.86 Support2: 5.10 |
| Resistance: |
Resistance1: 7.10 Resistance2: 8.29 |
| Pivot: |
6.17 |
| Moving Average: |
MA(5): 6.13 MA(20): 5.94
MA(100): 7.09  MA(250): 7.81 |
| MACD: |
MACD(12,26): 0.05 Signal(9): 0.03 |
| Stochastic oscillator: |
%K(14,3): 49.83 %D(3): 49.78 |
| RSI: |
RSI(14): 53.00 |
| 52-week: |
High: 13.70 Low: 4.86 Change(%): -26.3 |
| Average Vol(K): |
3-Month: 25613 10-Days: 16465 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.CRMD has closed above bottom band by 48.6%. Bollinger Bands are 29.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
2019-11-17
CorMedix (NYSEAMERICAN:CRMD) Stock Price Up 8.6% After Earnings Beat
Shares of CorMedix Inc. (NYSEAMERICAN:CRMD) rose 8.6% during mid-day trading on Friday after the company announced better than expected quarterly earnings. The stock traded as high as $5.70 and last traded at $5.56, approximately 255,727 shares traded hands during trading. A decline of 40% from the average daily volume of 424,898 shares. The stock had […]
2019-10-16
CorMedix Completes Successful CMC Interaction with the FDA
CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it has completed its interaction with the FDA related to the chemistry, manufacturing
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
